beta-Lactamase epidemiology and the utility of established and novel beta-lactamase inhibitors.
about
Probing substrate binding to metallo-beta-lactamase L1 from Stenotrophomonas maltophilia by using site-directed mutagenesisSuccinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-beta-lactamaseIdentification of a series of tricyclic natural products as potent broad-spectrum inhibitors of metallo-beta-lactamases.The 1.5-A structure of Chryseobacterium meningosepticum zinc beta-lactamase in complex with the inhibitor, D-captoprilMetallo-beta-lactamases: the quiet before the storm?Novelties in the field of anti-infective compounds in 1999.Overcoming antimicrobial resistance by targeting resistance mechanisms.The threat from the pink corner.Case studies of the spatial heterogeneity of DNA viruses in the cystic fibrosis lungCharacterization of monomeric L1 metallo-beta -lactamase and the role of the N-terminal extension in negative cooperativity and antibiotic hydrolysis.N-arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-beta-lactamase.Prior antibacterial peptide-mediated inhibition of protein folding in bacteria mutes resistance enzymes.Morphogen-defined patterning of Escherichia coli enabled by an externally tunable band-pass filter.Coordination geometries of metal ions in d- or l-captopril-inhibited metallo-beta-lactamases.Detection of a metallo-beta-lactamase (IMP-1) by fluorescent probes having dansyl and thiol groups.
P2860
Q24802987-2A5C8386-929D-4F35-B74C-2EDB87A545EFQ27632353-42AA79A4-A521-44BC-BD0D-A815CD3C90B5Q27639017-AF3A6634-2A2A-475B-A25C-9D253D6A756FQ27640947-E001232C-9DA5-47B6-96B1-9926CB11236BQ33755227-E8C0AABA-C4DC-484A-B882-8E3A753680A4Q34092340-900426B2-FCED-4D76-AEDD-F8DB42F2F071Q34211132-8C57B2C9-8681-4F29-832F-D08BFFA72571Q34212044-5BD7699F-A206-4FD8-AC5B-6AE1ED312217Q35991304-EFCFB470-A8EA-4FE2-B065-88DFAFB291D1Q38290404-C135AA8F-62A1-4D8F-B7A3-8BB90D7AE408Q39652530-4E662C84-280B-4053-B159-96D4BA100BD6Q41823699-11412819-0A85-42AE-991C-0CF0515A729CQ42057102-C22B625A-D2BA-41E0-A616-8000BB47029EQ44385766-39B87D65-4553-4BD6-8C63-667A1461A0C8Q44556618-559A4DE2-14F5-4277-B95F-FD9E07A59C54
P2860
beta-Lactamase epidemiology and the utility of established and novel beta-lactamase inhibitors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
beta-Lactamase epidemiology an ...... vel beta-lactamase inhibitors.
@ast
beta-Lactamase epidemiology an ...... vel beta-lactamase inhibitors.
@en
beta-Lactamase epidemiology an ...... vel beta-lactamase inhibitors.
@nl
type
label
beta-Lactamase epidemiology an ...... vel beta-lactamase inhibitors.
@ast
beta-Lactamase epidemiology an ...... vel beta-lactamase inhibitors.
@en
beta-Lactamase epidemiology an ...... vel beta-lactamase inhibitors.
@nl
prefLabel
beta-Lactamase epidemiology an ...... vel beta-lactamase inhibitors.
@ast
beta-Lactamase epidemiology an ...... vel beta-lactamase inhibitors.
@en
beta-Lactamase epidemiology an ...... vel beta-lactamase inhibitors.
@nl
P2093
P2860
P356
P1476
beta-Lactamase epidemiology an ...... vel beta-lactamase inhibitors.
@en
P2093
P2860
P304
P356
10.1517/13543784.9.2.247
P407
P577
2000-02-01T00:00:00Z